Established in 2015 as Jurnal Farmasains (p-ISSN: 2460-5182) by Department of Pharmacy, Faculty of Medical and Health Science, Universitas Islam Negeri Maulana Malik Ibrahim Malang. In 2016 transformed into online international Journal of Islamic Pharmacy (J.Islamic Pharm.) with full English version until late of 2019. We considered to accommodate researchers as broad as possible, thus starting with Volume 4, Number 2, December 2019, we receive manuscripts both in English and Indonesia.
Welcome to Journal of Islamic Pharmacy
JOURNAL HISTORY
Established in 2015 as Jurnal Farmasains (p-ISSN: 2460-5182; e-ISSN: 2527-6123) by Department of Pharmacy, Faculty of Medicine and Health Science, Universitas Islam Negeri Maulana Malik Ibrahim Malang. In 2016 transformed into Journal of Islamic Pharmacy (J. Islamic Pharm.). We considered to accommodate researchers as broad as possible, thus starting with Volume 4, Number 2, December 2019, we receive manuscripts both in English and Indonesia.
JOURNAL ACCREDITATION
J. Islamic Pharm. has been accredited (Sinta 5) by The Ministry of Higher Education, Science, and Technology of the Republic of Indonesia, as stated in Surat Keputusan Direktur Jenderal Pendidikan Tinggi, Riset, dan Teknologi No. 105/E/KPT/2022 for the period from Vol. 6 No. 1 (January-June) 2021 to Vol. 10 No. 2 (July-December) 2025.
FOCUS AND SCOPE
J. Islamic Pharm. publishes research papers, short communications, reviews and notes dealing with entire aspects of Pharmaceutical sciences, including: Pharmaceutical Chemistry, Analytical Chemistry, Medicinal Chemistry, Natural Product Chemistry, Pharmaceutical Biology, Pharmaceutical Microbiology and Biotechnology, Pharmacology Pharmacognosy, Computational Chemistry, Molecular Modeling, Drug Design, and Community and Clinical Pharmacy.
All articles are open access, which means it is freely available without any charge to users or institutions. This content licensing is in accordance with a CC-BY-SA license, thus all the materials should be given by appropriate credit and may not be used for commercial purposes.
Current Issue













